Evidence map›Paper›PMID 40426927›Full record

ArticleBiomedicines2025

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis.

Neya Ramanan, Mah-Noor Malik, Sarang Upneja, Haniya Farooq, Swati Kulkarni, Rasna Gupta, John Mathews, Abdullah Nasser, Alina Bocicariu, Laurice Arayan and 5 more

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Differential expression of NEAT1 and miR-506-3p in triple-negative breast cancer: potential tissue-based diagnostic biomarkers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Neya RamananSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.ORCID 0000-0002-2556-6532
Mah-Noor MalikSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Sarang UpnejaSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Haniya FarooqSchool of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.ORCID 0009-0005-3800-954X
Swati KulkarniSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Rasna GuptaSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
John MathewsSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Abdullah NasserSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.ORCID 0000-0002-1302-2861
Alina BocicariuSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Laurice ArayanSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.
Lisa PorterDepartment of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada.
Bre-Anne FifieldDepartment of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada.
Rong LuoLeddy Library, University of Windsor, Windsor, ON N9B 3P4, Canada.
Muriel BrackstoneSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.ORCID 0000-0002-7741-2199
Caroline HammSchulich School of Medicine and Dentistry, Western University, Windsor, ON N8W 2X3, Canada.ORCID 0000-0003-1326-2088

Funding

Western University XX
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is a heterogeneous cancer that lacks estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) proteins. Here, we investigated the prognostic value of grade in patients with TNBC.

Indexed as

breast cancergraderelapsesurvivaltriple negative

Identifiers

PMID40426927
PMCPMC12109397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.